EdgarLookup

AMERICAN INTERNATIONAL GROUP, INC. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that AMERICAN INTERNATIONAL GROUP, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
11.6%
Profit Margin
Net income ÷ revenue
1.9%
Return on Assets
Net income ÷ assets
2.92x
Debt-to-Equity
Total liabilities ÷ equity
+273.1%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $26.78B Feb 12, 2026
FY2024 Dec 31, 2024 $7.18B Feb 13, 2025
FY2024 Sep 30, 2024 $6.75B Feb 13, 2025
FY2024 Jun 30, 2024 $6.56B Feb 13, 2025
FY2024 Mar 31, 2024 $6.76B Feb 13, 2025
FY2024 Dec 31, 2023 $6.53B Feb 13, 2025
FY2024 Sep 30, 2023 $7.27B Feb 13, 2025
FY2024 Jun 30, 2023 $7.44B Feb 13, 2025
FY2024 Mar 31, 2023 $6.71B Feb 13, 2025
FY2024 Dec 31, 2022 $30.00B Feb 13, 2025

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.10B Feb 12, 2026
FY2024 Dec 31, 2024 $898.00M Feb 13, 2025
FY2024 Sep 30, 2024 $459.00M Feb 13, 2025
FY2024 Jun 30, 2024 ($3.98B) Feb 13, 2025
FY2024 Mar 31, 2024 $1.22B Feb 13, 2025
FY2024 Dec 31, 2023 $93.00M Feb 13, 2025
FY2024 Sep 30, 2023 $2.03B Feb 13, 2025
FY2024 Jun 30, 2023 $1.49B Feb 13, 2025
FY2024 Mar 31, 2023 $30.00M Feb 13, 2025
FY2024 Dec 31, 2022 $10.23B Feb 13, 2025

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.05B Feb 12, 2026
FY2025 Dec 31, 2024 $5.53B Feb 12, 2026
FY2025 Dec 31, 2023 $5.40B Feb 12, 2026
FY2024 Dec 31, 2022 $6.16B Feb 13, 2025
FY2023 Dec 31, 2021 $8.73B Feb 14, 2024
FY2022 Dec 31, 2020 $8.40B Feb 17, 2023
FY2021 Dec 31, 2019 $8.54B Feb 17, 2022
FY2020 Dec 31, 2018 $9.30B Feb 19, 2021
FY2019 Dec 31, 2017 $9.11B Feb 21, 2020
FY2018 Dec 31, 2016 $10.99B Feb 15, 2019

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.31B Feb 12, 2026
FY2025 Dec 31, 2024 $3.27B Feb 12, 2026
FY2025 Dec 31, 2023 $6.24B Feb 12, 2026
FY2024 Dec 31, 2022 $4.13B Feb 13, 2025
FY2023 Dec 31, 2021 $6.22B Feb 14, 2024
FY2022 Dec 31, 2020 $1.04B Feb 17, 2023
FY2021 Dec 31, 2019 ($1.81B) Feb 17, 2022
FY2020 Dec 31, 2018 ($394.00M) Feb 19, 2021
FY2019 Dec 31, 2017 ($7.82B) Feb 21, 2020
FY2018 Dec 31, 2016 $3.50B Feb 15, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $161.25B Feb 12, 2026
FY2025 Dec 31, 2024 $161.32B Feb 12, 2026
FY2024 Dec 31, 2023 $539.31B Feb 13, 2025
FY2023 Dec 31, 2022 $522.23B Feb 14, 2024
FY2022 Dec 31, 2021 $596.11B Feb 17, 2023
FY2023 Jan 1, 2021 $598.84B Feb 14, 2024
FY2021 Dec 31, 2020 $586.48B Feb 17, 2022
FY2020 Dec 31, 2019 $525.06B Feb 19, 2021
FY2019 Dec 31, 2018 $491.98B Feb 21, 2020
FY2018 Dec 31, 2017 $498.30B Feb 15, 2019

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $120.09B Feb 12, 2026
FY2025 Dec 31, 2024 $118.77B Feb 12, 2026
FY2024 Dec 31, 2023 $488.01B Feb 13, 2025
FY2023 Dec 31, 2022 $478.77B Feb 14, 2024
FY2022 Dec 31, 2021 $527.20B Feb 17, 2023
FY2023 Jan 1, 2021 $532.91B Feb 14, 2024
FY2021 Dec 31, 2020 $519.28B Feb 17, 2022
FY2020 Dec 31, 2019 $457.64B Feb 19, 2021
FY2019 Dec 31, 2018 $434.68B Feb 21, 2020
FY2018 Dec 31, 2017 $432.59B Feb 15, 2019

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $41.14B Feb 12, 2026
FY2025 Dec 31, 2024 $42.52B Feb 12, 2026
FY2024 Dec 31, 2023 $45.35B Feb 13, 2025
FY2023 Dec 31, 2022 $40.97B Feb 14, 2024
FY2022 Dec 31, 2021 $65.96B Feb 17, 2023
FY2023 Jan 1, 2021 $65.10B Feb 14, 2024
FY2021 Dec 31, 2020 $66.36B Feb 17, 2022
FY2020 Dec 31, 2019 $65.68B Feb 19, 2021
FY2019 Dec 31, 2018 $56.36B Feb 21, 2020
FY2018 Dec 31, 2017 $65.17B Feb 15, 2019

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.44B Feb 12, 2026
FY2025 Dec 31, 2024 $3.37B Feb 12, 2026
FY2025 Dec 31, 2023 $3.42B Feb 12, 2026
FY2024 Dec 31, 2022 $3.75B Feb 13, 2025
FY2023 Dec 31, 2021 $4.06B Feb 14, 2024
FY2022 Dec 31, 2020 $4.07B Feb 17, 2023
FY2021 Dec 31, 2019 $4.04B Feb 17, 2022
FY2021 Dec 31, 2018 $4.08B Feb 17, 2022
FY2020 Dec 31, 2017 $1.59B Feb 19, 2021
FY2019 Dec 31, 2016 $1.53B Feb 21, 2020

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $37.19B Feb 12, 2026
FY2025 Dec 31, 2024 $35.08B Feb 12, 2026
FY2024 Dec 31, 2023 $37.52B Feb 13, 2025
FY2023 Dec 31, 2022 $34.89B Feb 14, 2024
FY2022 Dec 31, 2021 $23.79B Feb 17, 2023
FY2023 Jan 1, 2021 $16.44B Feb 14, 2024
FY2021 Dec 31, 2020 $15.50B Feb 17, 2022
FY2020 Dec 31, 2019 $23.08B Feb 19, 2021
FY2019 Dec 31, 2018 $20.88B Feb 21, 2020
FY2018 Dec 31, 2017 $21.46B Feb 15, 2019

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $9.19B Feb 12, 2026
FY2025 Dec 31, 2024 $8.92B Feb 12, 2026
FY2024 Dec 31, 2023 $10.61B Feb 13, 2025
FY2022 Dec 31, 2022 $27.18B Feb 17, 2023
FY2022 Dec 31, 2021 $30.16B Feb 17, 2023
FY2021 Dec 31, 2020 $37.53B Feb 17, 2022
FY2020 Dec 31, 2019 $35.35B Feb 19, 2021
FY2019 Dec 31, 2018 $34.54B Feb 21, 2020
FY2018 Dec 31, 2017 $31.64B Feb 15, 2019
FY2017 Dec 31, 2016 $30.91B Feb 16, 2018

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 5 Feb 12, 2026
FY2025 Dec 31, 2024 (2) Feb 12, 2026
FY2025 Dec 31, 2023 5 Feb 12, 2026
FY2024 Dec 31, 2022 13 Feb 13, 2025
FY2023 Dec 31, 2021 12 Feb 14, 2024
FY2022 Dec 31, 2020 (6) Feb 17, 2023
FY2021 Dec 31, 2019 3 Feb 17, 2022
FY2020 Dec 31, 2018 0 Feb 19, 2021
FY2019 Dec 31, 2017 (6) Feb 21, 2020
FY2018 Dec 31, 2016 0 Feb 15, 2019

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 5 Feb 12, 2026
FY2025 Dec 31, 2024 (2) Feb 12, 2026
FY2025 Dec 31, 2023 4 Feb 12, 2026
FY2024 Dec 31, 2022 12 Feb 13, 2025
FY2023 Dec 31, 2021 11 Feb 14, 2024
FY2022 Dec 31, 2020 (6) Feb 17, 2023
FY2021 Dec 31, 2019 3 Feb 17, 2022
FY2020 Dec 31, 2018 0 Feb 19, 2021
FY2019 Dec 31, 2017 (6) Feb 21, 2020
FY2018 Dec 31, 2016 0 Feb 15, 2019

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 538.20M Feb 12, 2026
FY2025 Dec 31, 2024 606.10M Feb 12, 2026
FY2025 Dec 31, 2023 688.80M Feb 12, 2026
FY2025 Dec 31, 2022 734.10M Feb 12, 2026
FY2024 Dec 31, 2021 818.70M Feb 13, 2025
FY2023 Dec 31, 2020 861.60M Feb 14, 2024
FY2022 Dec 31, 2019 870.00M Feb 17, 2023
FY2021 Dec 31, 2018 866.61M Feb 17, 2022
FY2020 Dec 31, 2017 899.04M Feb 19, 2021
FY2019 Dec 31, 2016 995.34M Feb 21, 2020

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $976.00M Feb 12, 2026
FY2025 Dec 31, 2024 $1.00B Feb 12, 2026
FY2025 Dec 31, 2023 $997.00M Feb 12, 2026
FY2024 Dec 31, 2022 $982.00M Feb 13, 2025
FY2023 Dec 31, 2021 $1.08B Feb 14, 2024
FY2022 Dec 31, 2020 $1.10B Feb 17, 2023
FY2021 Dec 31, 2019 $1.11B Feb 17, 2022
FY2020 Dec 31, 2018 $1.14B Feb 19, 2021
FY2019 Dec 31, 2017 $1.17B Feb 21, 2020